PDCD1 and non-small cell lung carcinoma: For this reason, we decided to interrogate the French nation-wide ATHENA cohort, the largest real-world dataset on pembrolizumab treatment (n > 50,000),8 to identify possible effects of benzodiazepine medication on the clinical outcome of NSCLC patients treated with one single PD-1 antibody, pembrolizumab.